Pearl River Capital’s Royalty Pharma RPRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-24,062
Closed -$635K 306
2024
Q2
$635K Sell
24,062
-46,531
-66% -$1.29M 0.1% 243
2024
Q1
$2.14M Buy
70,593
+19,146
+37% +$564K 0.34% 91
2023
Q4
$1.45M Sell
51,447
-17,072
-25% -$469K 0.23% 133
2023
Q3
$1.86M Sell
68,519
-8,990
-12% -$267K 0.29% 116
2023
Q2
$2.38M Buy
+77,509
New +$2.63M 0.38% 77
2023
Q1
Sell
-36,796
Closed -$1.45M 603
2022
Q4
$1.45M Buy
36,796
+5,900
+19% +$246K 0.25% 128
2022
Q3
$1.24M Buy
+30,896
New +$1.32M 0.23% 141
2022
Q2
Sell
-23,024
Closed -$897K 549
2022
Q1
$897K Buy
23,024
+2,724
+13% +$107K 0.25% 126
2021
Q4
$809K Buy
20,300
+10,878
+115% +$423K 0.22% 149
2021
Q3
$341K Sell
9,422
-10,547
-53% -$410K 0.09% 288
2021
Q2
$819K Buy
+19,969
New +$849K 0.23% 148

Other funds holding RPRX